Literature DB >> 12543540

Polymicrobial candidemia.

Suzanne Pulimood1, Latha Ganesan, George Alangaden, Pranatharthi Chandrasekar.   

Abstract

We conducted a retrospective review of the clinical data on patients with polymicrobial candidemia during a nine-year period (1992-2000) at our tertiary care University Hospital. Also, the clinical features of patients with polymicrobial vs monomicrobial candidemia were compared. There were 16 (5.2%) patients with multiple candidal species in blood among 303 patients with candidemia. Patients' age varied from 21-85 years (median 52 years); they had serious underlying co-morbidities with prolonged hospitalization (median duration 13 days); all had intravenous vascular catheters, had been exposed to multiple antibiotics and were heavily colonized with Candida. Concomitant serious bacterial infections were common (56%). Candida albicans was isolated from blood in 11 of 16 patients; other species were C. glabrata (7 patients), C. tropicalis (6 patients) and C. parapsilosis (4 patients). Sixty seven percent (8 of 12) patients had causative Candida species isolated from vascular catheter tip culture. Polymicrobial candidemia occurred in sicker, non-oncologic patients with frequent concomitant bacterial infections, as compared to those with monomicrobial candidemia. Crude mortality was 43%, a rate similar to that seen with monomicrobial candidemia. Polymicrobial candidemia is uncommon, seen in hospitalized patients with multiple co-morbidities and heavy candidal colonization; removal of vascular catheter and institution of antifungal therapy are important therapeutic maneuvers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12543540     DOI: 10.1016/s0732-8893(02)00460-1

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  17 in total

1.  Letter to the editor-chronic disseminated candidiasis.

Authors:  Kenneth Rolston
Journal:  Support Care Cancer       Date:  2016-12-16       Impact factor: 3.603

Review 2.  Importance of Candida-bacterial polymicrobial biofilms in disease.

Authors:  Melphine M Harriott; Mairi C Noverr
Journal:  Trends Microbiol       Date:  2011-08-19       Impact factor: 17.079

Review 3.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

4.  Metabolic modelling of chronic wound microbiota predicts mutualistic interactions that drive community composition.

Authors:  P Phalak; M A Henson
Journal:  J Appl Microbiol       Date:  2019-09-09       Impact factor: 3.772

5.  Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Mark A Scheper; Jeff G Leid; John William Costerton; Mark E Shirtliff
Journal:  FEMS Immunol Med Microbiol       Date:  2010-06-07

Review 6.  Polymicrobial candidaemia revealed by peripheral blood smear and chromogenic medium.

Authors:  H Yera; D Poulain; A Lefebvre; D Camus; B Sendid
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

7.  Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections.

Authors:  S-H Kim; Y K Yoon; M J Kim; J W Sohn
Journal:  Clin Microbiol Infect       Date:  2012-06-01       Impact factor: 8.067

8.  Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

Authors:  Michael A Pfaller; David R Andes; Daniel J Diekema; David L Horn; Annette C Reboli; Coleman Rotstein; Billy Franks; Nkechi E Azie
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

9.  Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study.

Authors:  Mohan Pammi; Danni Zhong; Yvette Johnson; Paula Revell; James Versalovic
Journal:  BMC Infect Dis       Date:  2014-07-14       Impact factor: 3.090

10.  Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.

Authors:  Fasahat F Alam; Abu S Mustafa; Zia U Khan
Journal:  BMC Infect Dis       Date:  2007-09-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.